Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6604722.pdf
Reference47 articles.
1. Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA, Munger K (1999) Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc Natl Acad USA 96: 9637–9641
2. Alani RM, Young AZ, Shifflett CB (2001) Id1 regulation of cellular senescence through transcriptional repression of p16/Ink2a. Proc Natl Acad Sci USA 98: 7812–7816
3. Bodner-Adler B, Nather A, Bodner K, Czerwenka K, Kimberger O, Leodolter S, Mayerhofer K (2006) Expression of Thrombospondin 1 (TSP-1) in patients with uterine smooth muscle tumors: An Immunohistochemical Study. Gynecol Oncol 103: 186–189
4. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159
5. Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissell MJ, Campisi J (1998) A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol Cell Biol 18: 4577–4588
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Silibinin is a suppressor of the metastasis-promoting transcription factor ID3;Phytomedicine;2024-06
2. lncRNA LINC00652 is a significant prognostic and diagnostic biomarker in the Isfahan Breast cancer patients, correlated to ID1: integrated bioinformatics and experimental approach;2023-11-06
3. lncRNA LINC00652 is a significant prognostic and diagnostic biomarker in the Isfahan Breast cancer patients, correlated to ID1: integrated bioinformatics and experimental approach;2022-09-16
4. Anti-tumor effects of an ID antagonist with no observed acquired resistance;npj Breast Cancer;2021-05-24
5. PTBP3 Induced Inhibition of Differentiation of Gastric Cancer Cells Through Alternative Splicing of Id1;Frontiers in Oncology;2020-08-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3